Limitations of Hb F as a phenotypic modifier in sickle cell disease: Study of Kuwaiti Arab patients

Hemoglobin

Volumn 35, Issue 5-6, 2011, Pages 607-617

  Adekile, Adekunle D ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Hb F; Kuwaiti Arabs; Phenotype; Sickle cell disease

Indexed keywords

HEMOGLOBIN D; HEMOGLOBIN F; HYDROXYUREA;

ARAB; ARTICLE; AVASCULAR NECROSIS; BACTERIAL INFECTION; BETA THALASSEMIA; BRAIN BLOOD FLOW; BRAIN INFARCTION; CHILDHOOD; FEMUR HEAD AVASCULAR NECROSIS; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HIP RADIOGRAPHY; HUMAN; KUWAIT; LONGITUDINAL STUDY; LUNG FUNCTION; MORBIDITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PHENOTYPIC VARIATION; PNEUMOCOCCAL INFECTION; POPULATION GENETICS; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPLEEN FUNCTION; STROKE; TREATMENT RESPONSE;

ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; ARABS; FEMUR HEAD NECROSIS; FETAL HEMOGLOBIN; GENETIC ASSOCIATION STUDIES; HUMANS; HYDROXYUREA; KUWAIT; PHENOTYPE; STROKE; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS);

EID: 81055125419     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2011.617230     Document Type: Article

References (65)

1. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129(4): 465-481. (Pubitemid 40769896)
2. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N Engl J Med. 2008;359(21):2254-2265.
3. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37-47. (Pubitemid 46110926)
4. Rother R, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653-1662. (Pubitemid 40471796)
5. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysisassociated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279-2285. (Pubitemid 43345545)
6. KatoGJ, Martyr S, BlackwelderWC, et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol. 2005;130(6):943-953. (Pubitemid 43899735)
7. Gladwin MT, Rodgers GP. Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia. Lancet. 2000;355(9214):1476-1478. (Pubitemid 30237349)
8. Sebastiani P, Solovieff N, Hartley SW, et al. Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am J Hematol. 2010;85(1):29-35.
9. Adekile AD, Huisman THJ. Hb F in sickle cell anemia. Experientia. 1993;49(1):16-27. (Pubitemid 23041490)
10. Nagel RL. Severity, pathobiology, epistatic effects, and genetic markers in sickle cell anemia. Semin Hematol. 1991;28(3):180-201.
11. Chang YP, Maier-Redelsperger M, Smith KD, et al. The relative importance of the X-linked FCP locus and β-globin haplotypes in determining Haemoglobin F levels: a study of SS patients homozygous for βS haplotypes. Br J Haematol. 1997;96(4):806-814. (Pubitemid 27115878)
12. Thein SL, Menzel S. Discovering the genetics underlying foetal haemoglobin production in adults. Br J Haematol. 2009;145(4):455-467.
13. Thein SL. Genetic modifiers of the β-haemoglobinopathies. Br J Haematol. 2008;141(3):357-366.
14. Green NS, Barral S. Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease. Pediatr Blood Cancer. 2011;56(2):177-181.
15. Higgs DR, Aldridge BE, Lamb J, et al. The interaction of α-thalassemia and homozygous sickle-cell disease. N Engl J Med. 1982;306(24):1441-1446. (Pubitemid 12121575)
16. Mears JG, Lachman HM, Labie D, Nagel RL. α-Thalassemia is related to prolonged survival in sickle cell anemia. Blood. 1983;62(2):286-290. (Pubitemid 13036075)
17. Steinberg MH, Rosenstock W, Coleman MB, et al. Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood. 1984;63(6):1353-1360. (Pubitemid 14120380)
18. Adekile AD, Tuli M, Haider MZ, et al. Influence of α-thalassemia trait on spleen function in sickle cell anemia patients with high Hb F. Am J Hematol. 1996;53(1):1-5. (Pubitemid 26340429)
19. Steinberg MH, Rodgers GP. Pharmacologic modulation of fetal hemoglobin. Medicine (Baltimore). 2001;80(5):328-344. (Pubitemid 32879295)
20. Bookchin RM, Nagel RL, Balazs T. Role of hybrid tetramer formation in gelation of Haemoglobin S. Nature. 1975;256(5519):667-668.
21. Powars DR. Sickle cell anemia: βS-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol. 1991;28(3):202-208.
22. Antonarakis SE, Boehm CD, Serjeant GR, et al. Origin of the βS-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both. Proc Natl Acad Sci USA. 1984;81(3):853-856. (Pubitemid 14199042)
23. Powars DR. βS-Gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol Oncol Clin North Am. 1991;5(3):475-493.
24. Population of Kuwait (http://www.e.gov.kw/sites/kgoenglish/portal/Pages/ Visitors/AboutKuwait/ KuwaitAtaGlane-Population.aspx).
25. Abu-Hakima A. The modern history of Kuwait. London: Luzac & Co Ltd, 1983.
26. Adekile AD, Gu L-H, Baysal E, et al. Molecular characterization of α-thalassemia determinants, β-thalassemia alleles, and βS haplotypes among Kuwaiti Arabs. Acta Haematol. 1994;92(4):176-181.
27. Adekile AD, Haider MZ. Morbidity, βS haplotype and α-globin gene patterns among sickle cell anemia patients in Kuwait. Acta Haematol. 1996;96(3):150-154. (Pubitemid 26319297)
28. Adekile A, Al-Kandari M, Haider M, et al. Hemoglobin F concentration as a function of age in Kuwaiti sickle cell disease patients. Med Princ Pract. 2007;16(4):286-290. (Pubitemid 46854775)
29. Akar NA, Adekile A. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait. Med Princ Pract. 2008;17(5):404-408.
30. Owunwanne A, Halkar R, Al-Rasheed A, Abubacker KC, Abdel-Dayem H. Radionuclide imaging of the spleen with heat denatured technetium-99m RBC when the splenic reticuloendothelial system seems impaired. J Nucl Med. 1988;29(3):320-323. (Pubitemid 18086789)
31. Adekile AD, Owunwanne A, Al-Za'abi K, et al. Temporal sequence of splenic dysfunction in sickle cell disease. Am J Hematol. 2002;69(1):23-27.
32. Pearson HA, Gallagher D, Chilcote R, et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics. 1985;76(3):392-397. (Pubitemid 15242503)
33. Adekile AD, Gupta R, Yacoub F, et al. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of α-thalassemia trait. Acta Haematol. 2001;105(1):27-31. (Pubitemid 32424501)
34. Gupta R, Adekile AD. MRI follow-up and natural history of avascular necrosis of the femoral head in Kuwaiti children with sickle cell disease. J Pediatr Hematol Oncol. 004;26(6):351-353. (Pubitemid 38747724)
35. Marouf R, Gupta R, Haider MZ, Al-Wazzan H, Adekile AD. Avascular necrosis of the femoral head in adult Kuwaiti sickle cell disease patients. Acta Haematol. 2003;110(1):11-15. (Pubitemid 37140397)
36. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294. (Pubitemid 28018756)
37. Adekile AD, Yacoub F, Gupta R, et al. Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high Hb F. Am J Hematol. 2002;70(3):228-231. (Pubitemid 34680683)
38. Marouf R, Gupta R, Haider MZ, Adekile AD. Silent brain infarcts in adult Kuwaiti sickle cell disease patients. Am J Hematol. 2003;73(4):240-243. (Pubitemid 36898880)
39. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996;17(5): 965-972. (Pubitemid 26149101)
40. Al-Kandari FA, Owunwanne A, Syed GM, et al. Regional cerebral blood flow in patients with sickle cell disease: study with single photon emission computed tomography. Ann Nucl Med. 2007;21(8):439-445. (Pubitemid 47622167)
41. Siddiqui AK. Pulmonary manifestations of sickle cell disease. Postgrad Med J. 2003;79(933): 384-390. (Pubitemid 36993967)
42. Powars D, Weidman J, Odom-Maryon T, Niland J, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore). 1988;67(1):66-76. (Pubitemid 18064307)
43. Weil J, Castro O, Malik A, et al. Pathogenesis of lung disease in sickle hemoglobinopathies. Am Rev Respir Dis. 1993;148(1):249-256. (Pubitemid 23187252)
44. Santoli F, Zerah F, Vasile N, et al. Pulmonary function in sickle cell disease with or without acute chest syndrome. Eur Resp J. 1998;12(5):1124-1129. (Pubitemid 28545623)
45. Wall MA, Platt OS, Strieder DJ. Lung function in children with sickle cell anemia. Am Rev Respir Dis. 1979;120(1):210-214. (Pubitemid 9248787)
46. Bowen EF, Crowston JG, De Ceular K, Serjeant GR. Peak expiratory flow rate and the acute chest syndrome in homozygous sickle cell disease Arch Dis Child. 1991;66(3):330-332.
47. Koumbourlis AC, Lee DJ, Lee A. Longitudinal changes in lung function and somatic growth in children with sickle cell disease. Pediatr Pulmonol. 2007;42(6):483-488. (Pubitemid 46870378)
48. Koumbourlis AC, Hurlet-Jensen A, ByeMR. Lung function in infants with sickle cell disease. Pediatr Pulmonol. 1997;24(4):277-281. (Pubitemid 27484205)
49. Hijazi Z, Onadeko BO, Khadadah M, et al. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F. Int J Clin Pract. 2005;59(2):163-167. (Pubitemid 40331215)
50. Rodriguez GI, Kuhn JG, Weiss GR, et al. A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea. Blood. 1988;91(5):1533-1541.
51. Letvin NL, Linch DC, Beardsley P, McIntyre KW, Nathan DG. Augmentation of fetal hemoglobin in anemic monkeys by hydroxyurea. N Engl J Med. 1984;310(14):869-874.
52. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317-1322.
53. Charache S, Barton FB, Moore RD, et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore). 1996;75(6):300-326.
54. Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289(13):1645-1651. (Pubitemid 37430269)
55. Thompson BW, Miller ST, Rogers ZR, et al. The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer. 2010;54(2):250-255.
56. Hoppe C, Vichinsky E, Quirolo K, et al. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease. J Pediatr Hematol Oncol. 2000;22(4):330-334. (Pubitemid 32290173)
57. Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010;115(26):5300-5311.
58. Al-Jam'a AH, Al-Dabbous IA. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia. Saudi Med J. 2002;23(3):277-281. (Pubitemid 34296409)
59. Huisman THJ, Carver MFH, Efremov GD. A Syllabus of Human Hemoglobin Variants (Second Edition). Augusta: The Sickle Cell Anemia Foundation, 1998.
60. Kelleher JF, Park JOK, Kim HC, Schroeder WA. Life-threatening complications in a child with Hemoglobin SD-Los Angeles disease. Hemoglobin. 1984;8(3):203-213. (Pubitemid 14089754)
61. Mukherjee MB, Surve RR, Gangakhedkar RR, Mohanty D, Colah RB. Hemoglobin sickle D Punjab - case report. Indian J Hum Genet. 2005;11(3):154-156.
62. Adekile A, Mullah-Ali A, Akar NA. Does elevated Hemoglobin F modulate the phenotype in Hb SD-Los Angeles? Acta Haematol. 2010;123(3):135-139.
63. Adachi K, Kim J, Ballas S, Surrey S, Asakura T. Facilitation of Hb S polymerization by the substitution of Glu for Gln at β121. J Biol Chem. 1988;263(12):5607-5610.
64. Charache S, Conley CL. Rate of sickling of red cells during deoxygenation of blood from persons with various in sickling disorders. Blood. 1964;24(1):25-48.
65. Milner PF, Miller C, Grey R, Seakins M, DeJong WW, Went LN. Hemoglobin O Arab in four Negro families and its interaction with Hemoglobin S and Hemoglobin C. N Engl J Med. 1970;283(26):1413-1425.